BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25956029)

  • 1. The Nucleolar Protein GLTSCR2 Is an Upstream Negative Regulator of the Oncogenic Nucleophosmin-MYC Axis.
    Kim JY; Cho YE; Park JH
    Am J Pathol; 2015 Jul; 185(7):2061-8. PubMed ID: 25956029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer.
    Kim JY; Cho YE; An YM; Kim SH; Lee YG; Park JH; Lee S
    J Cell Mol Med; 2015 Jun; 19(6):1245-52. PubMed ID: 25818168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARF.
    Lee S; Cho YE; Kim SH; Kim YJ; Park JH
    Oncotarget; 2017 Mar; 8(10):16293-16302. PubMed ID: 27323397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription.
    Li Z; Hann SR
    Oncogene; 2013 Apr; 32(15):1988-94. PubMed ID: 22665062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Jun N-terminal kinase regulates the nucleoplasmic translocation and stability of nucleolar GLTSCR2 protein.
    Lee S; Cho YE; Kim YJ; Park JH
    Biochem Biophys Res Commun; 2016 Mar; 472(1):95-100. PubMed ID: 26903295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation.
    Li Z; Boone D; Hann SR
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18794-9. PubMed ID: 19033198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses.
    Lee S; Kim JY; Kim YJ; Seok KO; Kim JH; Chang YJ; Kang HY; Park JH
    Cell Death Differ; 2012 Oct; 19(10):1613-22. PubMed ID: 22522597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Myc-nucleophosmin-ARF network: a complex web unveiled.
    Li Z; Hann SR
    Cell Cycle; 2009 Sep; 8(17):2703-7. PubMed ID: 19652540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Playing both sides: nucleophosmin between tumor suppression and oncogenesis.
    Di Fiore PP
    J Cell Biol; 2008 Jul; 182(1):7-9. PubMed ID: 18625839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma.
    Bonetti P; Davoli T; Sironi C; Amati B; Pelicci PG; Colombo E
    J Cell Biol; 2008 Jul; 182(1):19-26. PubMed ID: 18625840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
    Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
    Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.
    Yeh CW; Huang SS; Lee RP; Yung BY
    Mol Pharmacol; 2006 Oct; 70(4):1443-53. PubMed ID: 16857742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
    Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
    Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleophosmin regulates the stability and transcriptional activity of p53.
    Colombo E; Marine JC; Danovi D; Falini B; Pelicci PG
    Nat Cell Biol; 2002 Jul; 4(7):529-33. PubMed ID: 12080348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.
    Li J; Sejas DP; Burma S; Chen DJ; Pang Q
    Carcinogenesis; 2007 Jun; 28(6):1163-70. PubMed ID: 17277230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Dose Actinomycin-D Induces Redistribution of Wild-Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells.
    Brodská B; Holoubek A; Otevřelová P; Kuželová K
    J Cell Biochem; 2016 Jun; 117(6):1319-29. PubMed ID: 26505272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor PNRC1 blocks rRNA maturation by recruiting the decapping complex to the nucleolus.
    Gaviraghi M; Vivori C; Pareja Sanchez Y; Invernizzi F; Cattaneo A; Santoliquido BM; Frenquelli M; Segalla S; Bachi A; Doglioni C; Pelechano V; Cittaro D; Tonon G
    EMBO J; 2018 Dec; 37(23):. PubMed ID: 30373810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleophosmin interacts with HEXIM1 and regulates RNA polymerase II transcription.
    Gurumurthy M; Tan CH; Ng R; Zeiger L; Lau J; Lee J; Dey A; Philp R; Li Q; Lim TM; Price DH; Lane DP; Chao SH
    J Mol Biol; 2008 Apr; 378(2):302-17. PubMed ID: 18371977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.